ExThera blood filter used to treat Covid-19

27 March 2020 (Last Updated March 27th, 2020 11:52)

Hospitals in Germany and Italy have begun using ExThera’s Seraph 100 Microbind Affinity Blood Filter to treat Covid-19.

Seraph 100 is the only haemoperfusion device approved for the reduction of pathogens in a patient’s bloodstream. Clinical results and virus binding studies suggest that the procedure should help in the treatment of Covid-19.

Whereas first-generation haemoperfusion devices remove only molecules, Seraph 100 is able to lower the concentration of bacteria, viruses and fungi in whole blood. It can significantly reduce the bloodstream concentration of both drug-susceptible and drug-resistant pathogens, the company said.

Read full story here.